Intensive temporal mapping of hepatitis C hypervariable region 1 quasispecies provides novel insights into hepatitis C virus evolution in chronic infection

被引:5
|
作者
Schmidt-Martin, Daniel [1 ]
Crosbie, Orla [2 ]
Kenny-Walsh, Elizabeth [2 ]
Fanning, Liam J. [1 ]
机构
[1] Natl Univ Ireland Cork, Cork Univ Hosp, Dept Med, Mol Virol Diagnost & Res Lab, Cork, Ireland
[2] Cork Univ Hosp, Dept Gastroenterol, Cork, Ireland
关键词
CHOLESTATIC HEPATITIS; DYNAMICS; HCV; INTERFERON; COMPLEXITY; DISEASE;
D O I
10.1099/vir.0.000149
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 ; 0836 ; 090102 ; 100705 ;
摘要
Hepatitis C virus (HCV) is an RNA virus which exists as swarms of closely related viruses known as quasispecies (QS). A number of studies have demonstrated associations between QS hypervariable region 1 (HVR1) characteristics (diversity and complexity) and treatment success. We investigated HCV QS change in chronic infection over intervals of 2-4 weeks in 23 chronically infected individuals to describe the natural history of virus evolution and establish whether HCV QS characteristics could be used to individualize treatment regimens at a molecular level. HVR1 QS diversity, complexity and divergence continue to change in an unpredictable fashion in chronic infection even where there is little phylogenetic change, which is likely to preclude the use of these features in treatment individualization. Our phylogenetic analysis identified no change in the HVR1 QS in 12 subjects, minor change in four subjects and we describe a time-ordered phylogeny for the first time over a period as short as 16 weeks in seven subjects. We identified the existence of multiple subpopulation infections using partitioned analysis of QS and illustrated how subpopulations were sequentially replaced in a number of subjects. We illustrated marked variation in the nucleotide substitution per codon position between patients with sequence change and those without change in the phylogenetic tree. Analysis of codon-specific selection pressures identified a number of codons under purifying selection, suggesting that these code for structurally conserved amino acids. We also identified sections of the HVR1 under positive selection with marked sequence heterogeneity, suggesting that these may be potential epitope-binding sites.
引用
收藏
页码:2145 / 2156
页数:12
相关论文
共 50 条
  • [41] Changes in hepatitis C virus infection routes and genotype distribution in a Lithuanian cohort with chronic hepatitis C
    Liakina, Valentina
    Speiciene, Danute
    Irnius, Algimantas
    Valantinas, Jonas
    MEDICAL SCIENCE MONITOR, 2009, 15 (04): : PH17 - PH23
  • [42] Factors associated with spontaneous clearance of chronic hepatitis C virus infection
    Bulteel, Naomi
    Sarathy, Prasanna Partha
    Forrest, Ewan
    Stanley, Adrian J.
    Innes, Hamish
    Mills, Peter R.
    Valerio, Heather
    Gunson, Rory N.
    Aitken, Celia
    Morris, Jude
    Fox, Ray
    Barclay, Stephen T.
    JOURNAL OF HEPATOLOGY, 2016, 65 (02) : 266 - 272
  • [43] High seroprevalence against hepatitis E virus in patients with chronic hepatitis C virus infection
    Mellgren, Asa
    Karlsson, Miriam
    Karlsson, Marie
    Lagging, Martin
    Wejstal, Rune
    Norder, Helene
    JOURNAL OF CLINICAL VIROLOGY, 2017, 88 : 39 - 45
  • [44] GB virus C/hepatitis G virus infection in chronic hepatitis C patients with and without interferon-α therapy
    Yu, ML
    Chuang, WL
    Dai, CY
    Chen, SC
    Lin, ZY
    Hsieh, MY
    Tsai, JF
    Wang, LY
    Chang, WY
    ANTIVIRAL RESEARCH, 2001, 52 (03) : 241 - 249
  • [45] Spouse-to-Spouse Transmission and Evolution of Hypervariable Region 1 and 5′ Untranslated Region of Hepatitis C Virus Analyzed by Next-Generation Sequencing
    Cortes, Kamila Caraballo
    Zagordi, Osvaldo
    Jablonska, Joanna
    Pawelczyk, Agnieszka
    Kubisa, Natalia
    Perlejewski, Karol
    Bukowska-Osko, Iwona
    Ploski, Rafal
    Radkowski, Marek
    Laskus, Tomasz
    PLOS ONE, 2016, 11 (02):
  • [46] Novel Therapies for Hepatitis C: Insights from the Structure of the Virus
    Fusco, Dahlene N.
    Chung, Raymond T.
    ANNUAL REVIEW OF MEDICINE, VOL 63, 2012, 63 : 373 - 387
  • [47] Iron and Proinflammatory Cytokines in Chronic Hepatitis C Virus Infection
    Lopez-Prieto, Javier
    Gonzalez-Reimers, Emilio
    Remedios Aleman-Valls, M.
    Jose de la Vega-Prieto, Maria
    Abreu-Gonzalez, Pedro
    Pelazas-Gonzalez, Ricardo
    Hernandez-Luis, Ruben
    Jorge-Ripper, Carlos
    Santolaria-Fernandez, Francisco
    BIOLOGICAL TRACE ELEMENT RESEARCH, 2013, 155 (01) : 5 - 10
  • [48] Treatment of early stage chronic hepatitis C virus infection
    Ponziani, Francesca Romana
    Miele, Luca
    Tortora, Annalisa
    Furnari, Manuele
    Bodini, Giorgia
    Pompili, Maurizio
    Gasbarrini, Antonio
    Giannini, Edoardo Giovanni
    EXPERT REVIEW OF CLINICAL PHARMACOLOGY, 2018, 11 (05) : 519 - 524
  • [49] Autoimmune thrombocytopenia related to chronic hepatitis C virus infection
    de Almeida, A. J.
    Campos-de-Magalhaes, M.
    Antonietti, C. L.
    Brandao-Mello, C. E.
    da Silva, M. L. P.
    de Oliveira, R. V.
    do Espirito-Santo, M. P.
    Yoshida, C. F. T.
    Lampe, E.
    HEMATOLOGY, 2009, 14 (01) : 49 - 58
  • [50] Glecaprevir/pibrentasvir for the treatment of chronic hepatitis C virus infection
    Mensa, Federico J.
    Lovell, Sandra
    Pilot-Matias, Tami
    Liu, Wei
    FUTURE MICROBIOLOGY, 2019, 14 (02) : 89 - 110